The treatment of toxocaral infection: some experimental and clinical observations.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001196:Ascariasis / Q000188:drug therapy* / Q000276:immunology; D001798:Blood Proteins / Q000032:analysis; D002675:Child, Preschool; D004049:Diethylcarbamazine / Q000627:therapeutic use*; D005455:Fluorescent Antibody Technique; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D013827:Thiabendazole / Q000627:therapeutic use*; D013997:Time Factors; D014119:Toxocara / Q000187:drug effects; D005719:gamma-Globulins / Q000032:analysis
D000906:Antibodies; D001798:Blood Proteins; D005719:gamma-Globulins; D013827:Thiabendazole; D004049:Diethylcarbamazine